share_log

康寧傑瑞製藥-B：截至二零二三年十二月三十一日止月份之股份發行人的證券變動月報表

ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 4 06:00
Summary by Moomoo AI
康宁杰瑞制药-B（09966）於2024年1月4日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在該月份均無變動，普通股股份數目維持在25,100,000,000股，面值為0.000002美元，法定/註冊股本總額為50,200美元。已發行股份結存為964,843,807股。此外，報告中提及的股份期權計劃包括首次公開發售前後的購股權計劃，但本月內並無股份期權行使，因此沒有新股份發行。公司確認所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
康宁杰瑞制药-B（09966）於2024年1月4日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本及已發行股份在該月份均無變動，普通股股份數目維持在25,100,000,000股，面值為0.000002美元，法定/註冊股本總額為50,200美元。已發行股份結存為964,843,807股。此外，報告中提及的股份期權計劃包括首次公開發售前後的購股權計劃，但本月內並無股份期權行使，因此沒有新股份發行。公司確認所有證券發行均已獲得董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Conning Jerry Pharmaceuticals-B (09966) filed with Hong Kong Trading and Settlement Limited on 4 January 2024 its Statement of Monthly Changes in Securities for the year ended 31 December 2023. The report shows that the company's regulary/registered share capital and issued shares were unchanged during the month, with the number of ordinary shares remaining at 25,100,000,000 shares with a face value of $0.00000002 and a total regulated/registered share capital of $50,200. The issued shares were recorded at 964,843,807 shares. In addition, the share option plan referred to in the report includes a pre- and post-IPO share option plan, but no stock options were exercised during this month and therefore no new shares were issued. The Company confirms that all issuance of securities has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Conning Jerry Pharmaceuticals-B (09966) filed with Hong Kong Trading and Settlement Limited on 4 January 2024 its Statement of Monthly Changes in Securities for the year ended 31 December 2023. The report shows that the company's regulary/registered share capital and issued shares were unchanged during the month, with the number of ordinary shares remaining at 25,100,000,000 shares with a face value of $0.00000002 and a total regulated/registered share capital of $50,200. The issued shares were recorded at 964,843,807 shares. In addition, the share option plan referred to in the report includes a pre- and post-IPO share option plan, but no stock options were exercised during this month and therefore no new shares were issued. The Company confirms that all issuance of securities has been authorised by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more